FY2025 · ended Dec 31, 2025 · Revenue $249.60M, +13.5% YoY · Filed Feb 26, 2026
Lemaitre Vascular, Inc. (LMAT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $249.6 million and net income of $57.7 million. Free cash flow was $74.5 million. As of Sep 30, 2026 it held $389.7 million in cash and investments and $19.5 million in total debt.
Revenue (TTM)
$269.36M
+11.8% vs year-ago TTM
Net income (TTM)
$63.34M
+18.7% vs year-ago TTM
Operating cash flow (TTM)
$76.20M
+4.0% vs year-ago TTM
Free cash flow (TTM)
$67.00M
+1.2% vs year-ago TTM
EPS (TTM)
$2.75
+18.1% vs year-ago TTM
Dividend per share (TTM)
$0.95
+25.0% vs year-ago TTM
Shares outstanding
22.78M
+1.0% vs prior year
Net cash
$370.19M
as of Sep 30, 2026
Operating margin
27.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- LMAT (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Burlington, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1158895
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $249.6M | $219.9M | $193.5M | $161.7M | $154.4M |
| Operating income | $67.9M | $52.3M | $36.7M | $26.8M | $36.4M |
| Net income | $57.7M | $44.0M | $30.1M | $20.6M | $26.9M |
| Diluted EPS | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 |
| Operating cash flow | $81.3M | $44.1M | $36.8M | $25.4M | $35.1M |
| Free cash flow | $74.5M | $37.2M | $29.5M | $22.1M | $30.2M |
| Total assets | $615.7M | $551.8M | $346.8M | $310.5M | $292.8M |
| Total liabilities | $222.2M | $214.5M | $48.9M | $42.3M | $38.7M |
| Stockholders' equity | $393.5M | $337.3M | $297.9M | $268.2M | $254.2M |
| Cash and investments | $359.1M | $299.7M | $105.1M | $82.7M | $70.0M |
| Total debt | $16.9M | $17.9M | $19.1M | $16.6M | $15.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2026 | Oct 9, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2026 | Jun 2, 2026 |
All 1002 Lemaitre Vascular, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.